Sue O'Dorisio

Academic / Other · 6 registered clinical trials.

Status	Trial	Phase	Started
Withdrawn	Dosimetry Guided PRRT With 177Lu-DOTATATE in Children and Adolescents Neuroendocrine Tumors, Pheochromocytoma, Paraganglioma	Phase 1 / Phase 2	2020-08-04
Withdrawn	Dosimetry Guided PRRT With 90Y-DOTATOC Neuroendrocrine Tumors, Meningioma, Neuroblastoma	Phase 2	2017-01-01
Completed	Impact of Ga-68 DOTATOC PET-CT Imaging in Management of Neuroendocrine Tumors Neuroendocrine Tumors, Carcinoid Tumors, Neuroblastoma	Phase 2	2015-09-01
Withdrawn	Efficacy of 68Ga-DOTATOC Positron Emission Tomography (PET) CT in Children and Young Adults With Brain Tumors Acoustic Schwannoma, Adult Anaplastic Astrocytoma, Adult Anaplastic Ependymoma	N/A	2013-09-01
Completed	Comparative Study of Sensitivity of Ga-DOTATOC PET vs Octreoscan SPECT + CT Adult Medulloblastoma, Childhood Medulloblastoma, Neuroblastoma	Phase 2	2013-04-01
Completed	Safety of 68Ga-DOTA-tyr3-Octreotide PET in Diagnosis of Solid Tumors Neuroendocrine Tumors, Carcinoid Tumors, Neuroblastoma	Phase 1 / Phase 2	2012-02-21